442
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly

, , , &
Pages 538-546 | Received 20 Mar 2018, Accepted 10 Jun 2018, Published online: 04 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhiguang Li, Mei Tian, Hongning Jia, Xin Li, Qi Liu, Xiaomeng Zhou, Rui Li, Hui Dong & Yaling Liu. (2023) Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-10.
Read now
Ruth M. Pfeiffer, Bernd Mayer, Ralph W. Kuncl, David P. Check, Elizabeth K. Cahoon, Donna R. Rivera & D. Michal Freedman. (2020) Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 235-245.
Read now

Articles from other publishers (12)

Collin J. Kreple, Susan Searles Nielsen, Kathleen M. Schoch, Tao Shen, Mark Shabsovich, Yizhe Song, Brad A. Racette & Timothy M. Miller. (2023) Protective Effects of Lovastatin in a Population‐Based ALS Study and Mouse Model . Annals of Neurology 93:5, pages 881-892.
Crossref
Nan Hu & Hongyan Ji. (2022) Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurological Sciences 43:9, pages 5189-5199.
Crossref
Can Cui, Jiangwei Sun, Kyla A. McKay, Caroline Ingre & Fang Fang. (2022) Medication use and risk of amyotrophic lateral sclerosis—a systematic review. BMC Medicine 20:1.
Crossref
Fardin Nabizadeh, Mohammad Balabandian, Amir Mohammad Sharafi, Ali Ghaderi, Mohammad Reza Rostami & Abdorreza Naser Moghadasi. (2021) Statins and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Acta Neurologica Belgica 122:4, pages 979-986.
Crossref
Marc G Weisskopf, Joseph Levy, Aisha S Dickerson, Sabrina Paganoni & Maya Leventer-Roberts. (2022) Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality. American Journal of Epidemiology 191:7, pages 1248-1257.
Crossref
Anna Gaimari, Michele Fusaroli, Emanuel Raschi, Elisa Baldin, Luca Vignatelli, Francesco Nonino, Fabrizio De Ponti, Jessica Mandrioli & Elisabetta Poluzzi. (2022) Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System. Drug Safety 45:6, pages 663-673.
Crossref
Nils Skajaa, Istvan Bakos, Erzsébet Horváth-Puhó, Victor W. Henderson, Timothy L. LashHenrik Toft Sørensen. (2021) Statin Initiation and Risk of Amyotrophic Lateral Sclerosis. Epidemiology 32:5, pages 756-762.
Crossref
Júlia Canet-Pons, Nesli-Ece Sen, Aleksandar Arsović, Luis-Enrique Almaguer-Mederos, Melanie V. Halbach, Jana Key, Claudia Döring, Anja Kerksiek, Gina Picchiarelli, Raphaelle Cassel, Frédérique René, Stéphane Dieterlé, Nina V. Fuchs, Renate König, Luc Dupuis, Dieter Lütjohann, Suzana Gispert & Georg Auburger. (2021) Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiology of Disease 152, pages 105289.
Crossref
Min Cheol Chang, Sang Gyu Kwak, Jin-Sung Park & Donghwi Park. (2021) Relationship between statins and the risk of amyotrophic lateral sclerosis. Medicine 100:30, pages e26751.
Crossref
D. Mariosa, F. Kamel, R. Bellocco, L.‐O. Ronnevi, C. Almqvist, H. Larsson, W. Ye & F. Fang. (2020) Antidiabetics, statins and the risk of amyotrophic lateral sclerosis. European Journal of Neurology 27:6, pages 1010-1016.
Crossref
Yan Fang, Xing-hui Li, Yan Qiao, Nan Wang, Ping Xie, Gang Zhou, Peng Su, Hui-yuan Ma & Ji-yang Song. (2020) Prevalence of dyslipidemia in Tibetan monks from Gansu Province, Northwest China. Open Life Sciences 15:1, pages 152-158.
Crossref
Leila Bond, Gloria Bowen, Benjamin Mertens, Keelie Denson, Kathleen Jordan, Branislav Vidakovic & Cassie S. Mitchell. (2020) Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration. Behavioral Sciences 10:1, pages 33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.